K TREATMENTS
LIVE

Serial Number

79400910

Owner

PANIZZA ALESSIA

Attorney

Daniel M. Gurfinkel

Filing Date

Oct 13, 2023

Add to watchlist:

No watchlists yet
View on USPTO

K TREATMENTS Trademark

Serial Number: 79400910 • Registration: 7617332

K TREATMENTS is a trademark filed by PANIZZA ALESSIA on October 13, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

PANIZZA ALESSIA

Via Betta, 4

Entity Type: 01

Trademark Details

Filing Date

October 13, 2023

Registration Date

December 24, 2024

Published for Opposition

November 5, 2024

Goods & Services

Adjuvants for medical purposes; Medicinal healthcare preparations, namely, for the treatment of heavy metal detox, vaginal infections, inhalation allergies, pain, insomnia, hormonal disorders; Sanitary preparations for medical use; Food supplements; Natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Nutritional supplements; Vitamin supplements; Protein supplements; Diagnostic preparations for medical or veterinary purposes; Pharmaceuticals for the treatment of erectile dysfunction; Vitamins and vitamin preparations; quantum-medical preparations and bio-cybernetic pharmaceutical preparations for the treatment of heavy metal detox, vaginal infections, inhalation allergies, pain, insomnia, hormonal disorders and for hormonal system regulation; Medical preparations for slimming purposes; Nasal spray preparations; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Anti-inflammatory preparations; Pharmaceutical preparations for suppressing tumors; tumor suppressing agents; Pharmaceutical preparations for the treatment of viral diseases; Vaginal moisturizers; Vaginal lubricants; Vaginal antifungals; Vaginal washes for medical purposes; Vaginal suppositories for the prevention and treatment of infections

Performing bio-cybernetic diagnosis of diseases; Health care services, namely, bio-cybernetics therapy; medical services; Performing diagnosis of diseases using quantum-mechanics; medical treatment using quantum-chemical and quantum-physical technology; Regenerative medicine services; Alternative medicine services; Health assessment services; Providing nutritional information about food; Consulting services in the fields of health and nutrition

Research in the field of quantum physics and quantum chemistry; Research in the field of quantum communication technology; Research and development in the medical and biotechnology fields; Research and development in the medical field for pain treatment; Consulting services in the field of biotechnology; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Research in the field of bio-cybernetic regulators; custom design of quantum electromagnetic transformers; custom design of quantum electromagnetic inductors; custom design of quantum electromagnetic transformers and electromagnetic inductors for pain treatment; Technical consultancy in relation to technical research in the field of food and beverages; Cosmetic research; Scientific research relating to cosmetics; resarch laboratory analysis in the field of cosmetics; Testing of cosmetics

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 12, 2026 OPNX
NEW REPRESENTATIVE AT IB RECEIVED
Feb 5, 2026 NREP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 24, 2025 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 5, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 18, 2025 FICS
FINAL DISPOSITION PROCESSED
Jun 18, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 25, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 24, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 24, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 5, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 5, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 16, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 27, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 27, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 27, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 27, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 24, 2024 TROA
REFUSAL PROCESSED BY IB
Sep 9, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 20, 2024 RFCS
REFUSAL PROCESSED BY MPU
Aug 20, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 10, 2024 RFCR
NON-FINAL ACTION WRITTEN
Aug 9, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 8, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 7, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 7, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 25, 2024 REPR